PATENT CLAIM ANALYSIS

Application Number: 15749351
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "023000"]

Abstract:
This invention relates to compositions for use in the treatment of diabetes, for example type-2 diabetes; obesity; and/or metabolic syndrome. Specifically, the invention relates to a composition for use in the treatment of diabetes, the composition comprising at least one of diindolylmethane; indole-3-carbinol; embelin; [6]-gingerol; and [6]-shogaol, or combinations each thereof. Also disclosed is use in the treatment of obesity and use in the treatment of metabolic syndrome.

Claim (Index 12):
The method of  claim 2 , wherein the composition is administered in an amount such that the embelin is administered in an amount of 0.1 \u03bcmol/kg to 50 \u03bcmol/kg body weight of said subject.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.97727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15115532', '11713892', '15307248', '12001449', '11090825']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7798358038795519
- 35 USC 102 Novelty (BERT): 0.5307860130886181
- Combined Prediction Score: 0.7549308248004585
- Mean Citation Score: 265.206966
- Max Citation Score: 335.04977
- Similarity Product: 186.1082150874388

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test